Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
International Journal of Immunopathology and Pharmacology|February 20, 2003
Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART studyN. Gianotti, M. Setti, P. E. Manconi, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1988
Liver autoreactivity in acute virus A, B and non-A, non-B hepatitisS Vento, B M McFarlane, C G McSorley, et al.
Pain|January 10, 2019
Extended-release gabapentin for failed back surgery syndrome: results from a randomized double-blind cross-over studyJennifer S Gewandter, Maria E Frazer, Xueya Cai, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 1998
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosisF Barchiesi, D Arzeni, M S Del Prete, et al.
The Journal of Infectious Diseases|May 24, 2000
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis studyC Mussini, P Pezzotti, A Govoni, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study GroupV Joly, M Moroni, E Concia, et al.
The Journal of Infectious Diseases|February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infectionM Floridia, S Vella, A C Seeber, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
The Journal of Infectious Diseases|April 1, 1997
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replicationM D de Jong, S Vella, A Carr, et al.
Pageof 19